DHR:NYSEDanaher Corporation Analysis
Data as of 2026-02-21 - not real-time
$210.96
Latest Price
4/10Risk
Risk Level: Medium
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Technical indicators show a short-term bearish trend and stock is trading below its 20 and 50-day moving averages.
- Awaiting market reaction and earnings clarity following the massive $9.9 billion Masimo acquisition.
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong free cash flow generation and low leverage support the integration of the recently acquired Masimo business.
- Analyst consensus highlights significant upside with average price targets around $260.
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Dominant market position in life sciences and diagnostics provides a wide economic moat.
- Consistent dividend growth and resilient long-term non-GAAP core revenue expansion.
Key Metrics & Analysis
Financial Health
Revenue Growth-1.70%
Profit Margin14.70%
P/E Ratio42.1
ROE7.10%
ROA4.40%
Debt/Equity0.35
P/B Ratio2.9
Op. Cash Flow$6.4B
Free Cash Flow$5.3B
Industry P/E35.6
Technical Analysis
TrendBearish
RSI37.8
Support$203.31
Resistance$225.41
MA 20$224.94
MA 50$228.24
MA 200$208.85
MACDBearish
VolumeIncreasing
Fear & Greed Index45
Valuation
Fair Value$235.56
Target Price$261.04
Upside/Downside23.70%
GradeFair
TypeBlend
Dividend Yield0.60%
Risk Assessment
Beta0.91
Volatility18.50%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.